McDonough Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$938K Buy
782
+11
+1% +$11.2K 0.47% 27
2026
Q1
$709K Buy
771
+7
+0.9% +$7.1K 0.39% 29
2025
Q4
$821K Sell
764
-19
-2% -$18.2K 0.4% 27
2025
Q3
$598K Buy
783
+12
+2% +$8.93K 0.3% 31
2025
Q2
$601K Buy
771
+27
+4% +$21K 0.34% 31
2025
Q1
$615K Buy
744
+118
+19% +$98.2K 0.4% 30
2024
Q4
$483K Buy
626
+15
+2% +$12.4K 0.3% 32
2024
Q3
$541K Hold
611
0.37% 29
2024
Q2
$553K Buy
611
+14
+2% +$11.2K 0.4% 28
2024
Q1
$464K Buy
+597
New +$425K 0.37% 28

Other funds holding LLY

McDonough Capital Management's LLY Position: Q2 2026 in Review

McDonough Capital Management increased its Eli Lilly (LLY) stake by 1.4% in Q2 2026, buying an estimated $11.2K and bringing the position to 782 shares worth $938K. The position accounts for 0.47% of the portfolio, ranked #27.

McDonough Capital Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • McDonough Capital Management held 782 shares of Eli Lilly worth $938K as of Q2 2026.
  • McDonough Capital Management bought 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.47% of McDonough Capital Management's portfolio in Q2 2026, its #27 holding.
  • McDonough Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on McDonough Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.